Two Seas Capital’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
FIA
PWMG
Two Seas Capital's IMVT Position: Q3 2026 in Review
Two Seas Capital increased its Immunovant (IMVT) stake by 47% in Q3 2026, buying an estimated $57.7M and bringing the position to 4,612,692 shares worth $156M. The position accounts for 1.8% of the portfolio, ranked #9.
Two Seas Capital first reported a position in IMVT in Q3 2023 and has held it in 13 quarters since. 14 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.
- Two Seas Capital held 4,612,692 shares of Immunovant worth $156M as of Q3 2026.
- Two Seas Capital bought 1,464,187 Immunovant shares in Q3 2026, an estimated $57.7M.
- Immunovant made up 1.8% of Two Seas Capital's portfolio in Q3 2026, its #9 holding.
- Two Seas Capital first reported a position in Immunovant in Q3 2023 and has held it in 13 quarters since.
- 14 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.
Based on Two Seas Capital's 13F filing for Q3 2026, filed 6 Oct 2026.